NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT02632448 2025-05-02A Study of LY2880070 in Participants With Advanced or Metastatic CancerEsperas Pharma Inc.Phase 1/2 Completed229 enrolled
NCT03997968 2024-12-24A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCyteir Therapeutics, Inc.Phase 1/2 Completed169 enrolled
NCT01325558 2016-07-15A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsAltor BioSciencePhase 1 Completed30 enrolled
NCT00440622 2013-02-13Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsHellenic Oncology Research GroupPhase 3 Terminated90 enrolled